We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$5.08B
AUM Growth
+$313M
Cap. Flow
+$149M
Cap. Flow %
2.94%
Top 10 Hldgs %
42.96%
Holding
128
New
10
Increased
56
Reduced
53
Closed
7

Top Buys

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$115M
2
BIDU icon
Baidu
BIDU
+$101M
3
TCOM icon
Trip.com Group
TCOM
+$52.3M
4
HSY icon
Hershey
HSY
+$48.7M
5
ELV icon
Elevance Health
ELV
+$47.6M

Top Sells

Rank Stock Value
1
SIVB
SVB Financial Group
SIVB
+$89.1M
2
TSLA icon
Tesla
TSLA
+$54.6M
3
EL icon
Estee Lauder
EL
+$52.1M
4
COST icon
Costco
COST
+$44.3M
5
BX icon
Blackstone
BX
+$38.4M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Healthcare 21.42%
3 Financials 11.75%
4 Consumer Discretionary 10.47%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBN icon
101
ICICI Bank
IBN
$108B
$2.43M 0.05%
+111,100
New +$2.47M
THRM icon
102
Gentherm
THRM
$1.27B
$1.96M 0.04%
29,960
-8,225
-22% -$531K
ELF icon
103
e.l.f. Beauty
ELF
$5.6B
$1.85M 0.04%
+33,437
New +$1.64M
MMSI icon
104
Merit Medical Systems
MMSI
$5.34B
$1.82M 0.04%
+25,725
New +$1.72M
SQM icon
105
Sociedad Química y Minera de Chile
SQM
$20.8B
$1.78M 0.04%
22,340
-33,381
-60% -$3.09M
JD icon
106
JD.com
JD
$45B
$1.76M 0.03%
31,305
+8,575
+38% +$431K
VRNT
107
DELISTED
Verint Systems
VRNT
$1.67M 0.03%
46,010
-74,645
-62% -$2.69M
IVV icon
108
iShares Core S&P 500 ETF
IVV
$904B
$1.65M 0.03%
4,300
-1,500
-26% -$579K
FDS icon
109
Factset
FDS
$10.1B
$1.38M 0.03%
3,440
+293
+9% +$125K
APLS
110
DELISTED
Apellis Pharmaceuticals
APLS
$1.31M 0.03%
25,348
-6,627
-21% -$351K
BOOT icon
111
Boot Barn
BOOT
$5.05B
$1.26M 0.02%
20,180
-18,860
-48% -$1.13M
UTHR icon
112
United Therapeutics
UTHR
$22.8B
$1.24M 0.02%
4,466
-33
-0.7% -$8.33K
AGYS icon
113
Agilysys
AGYS
$3.05B
$1.2M 0.02%
+15,156
New +$966K
PBH icon
114
Prestige Consumer Healthcare
PBH
$2.49B
$1.13M 0.02%
18,120
-17,305
-49% -$992K
CDNS icon
115
Cadence Design Systems
CDNS
$92.1B
$1.03M 0.02%
+6,409
New +$1.02M
OMCL icon
116
Omnicell
OMCL
$1.69B
$903K 0.02%
17,915
-1,335
-7% -$80.2K
CVX icon
117
Chevron
CVX
$381B
$815K 0.02%
4,540
+1,280
+39% +$223K
OLLI icon
118
Ollie's Bargain Outlet
OLLI
$4.78B
$810K 0.02%
17,285
-39,490
-70% -$2.13M
SKIN icon
119
SkinHealth Systems
SKIN
$83.6M
$749K 0.01%
82,260
-81,312
-50% -$878K
SUPN icon
120
Supernus Pharmaceuticals
SUPN
$2.74B
$722K 0.01%
+20,240
New +$703K
TYL icon
121
Tyler Technologies
TYL
$13B
$361K 0.01%
1,120
AMX icon
122
America Movil
AMX
$71.5B
-299,390
Closed -$4.93M
DLO icon
123
dLocal
DLO
$4.22B
-751,570
Closed -$15.4M
NTR icon
124
Nutrien
NTR
$31.4B
-273,299
Closed -$22.8M
PYPL icon
125
PayPal
PYPL
$50.2B
-18,192
Closed -$1.57M

Similar funds

Axiom Investors's Q4 2022 Portfolio in Review

As of Q4 2022, Axiom Investors held 128 positions worth $5.08B, up 6.6% from $4.77B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Axiom Investors's Q4 2022 filing shows 10 new, 56 increased, 53 reduced and 7 closed positions. Its largest new stake was Arthur J. Gallagher & Co: 616,600 shares worth $116M. The largest sale was SVB Financial Group, an estimated $89.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axiom Investors's largest Q4 2022 buy was Arthur J. Gallagher & Co: 616,600 shares worth $116M.
  • Axiom Investors added most to Baidu in Q4 2022, an estimated $101M increase.
  • Axiom Investors's biggest Q4 2022 reduction was Tesla, cutting an estimated $54.6M.
  • Axiom Investors fully exited SVB Financial Group in Q4 2022, selling an estimated $89.1M.
  • Axiom Investors's ten largest holdings make up 43% of its $5.08B portfolio in Q4 2022.
  • Axiom Investors opened 10 new positions and closed 7 in Q4 2022.
  • Axiom Investors's portfolio value rose 6.6% quarter-over-quarter to $5.08B.

Based on Axiom Investors's 13F filing for Q4 2022, filed 9 Feb 2023.